Indeed, another study focused on blocking the IL-8 receptor CXCR1 using repertaxin, which selectively depleted CSC population in human breast cancer lines [149], confirming the role of this interleukin in maintaining the tumor stem population. The gene discussed is CXCR1; the disease is breast carcinoma.